FDA Enforcement Class II Terminated

Access BR Monitor, Part No. 387620

Recall: Z-2074-2017 · Reported May 24, 2017

Enforcement

Recall Number
Z-2074-2017
Event ID
77029
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Beckman Coulter Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
May 24, 2017
Initiation Date
April 13, 2017
Classification Date
May 12, 2017
Termination Date
June 4, 2018
Address
250 S Kraemer Blvd, Brea, CA, 92821-6232, United States

Description

Access BR Monitor, Part No. 387620

Reason

Following biases observed in the results of the French National Quality Controls, Beckman Coulter has been informed that a study completed by the French Competent Authority Agence nationale de s¿curit¿ du Medicament et des produits de sant¿ (ANSM) showed diagnosed cancer patients in non-remission of their metastatic disease, may have results below the upper reference limit (URL) of 31.3 U/mL as stated in the Access BR Monitor instructions for use (IFU).

Code Info

623913, 625701, 628771, 630349, 633070 and All Future Lots

Distribution

Affected geographies: Algeria, Australia, Austria, Bangladesh, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Ecuador, Egypt, El Salvador, France, Georgia, Germany, Ghana, Gibraltar, Greece, Guam, Guatemala, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Lebanon, Libya, Lithuania, Malaysia, Mayotte, Mexico, Morocco, Myanmar, Namibia, Nepal, Netherlands, New Zealand, Nigeria, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Romania, Russia, Rwanda, Saudi Arabia, Serbia, Sierra Leone, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Venezuela, Vietnam, Zimbabwe

Quantity

45,278 units total (2,419 units in US)